Your search for multiple sclerosis returned 215 results

Your search for multiple sclerosis returned 215 results

Sort Results:

Relevant Recent
News, Stat Consult

Stat Consult: Gastroparesis

This review provides a concise overview of the incidence, risk factors, pathogenesis, diagnostic criteria, differential diagnosis, and treatment of gastroparesis.
Imaging

Multiple Sclerosis

OVERVIEW: What every practitioner needs to know Are you sure your patient has Multiple Sclerosis? What are the typical findings for this disease? A first attack of neurological symptoms in children with central nervous system (CNS) demyelination may represent a monophasic illness or be the first presentation of a chronic relapsing disorder such as multiple…
LabMed

Multiple Sclerosis

At a Glance MS is considered in the presence of clinically objective neurologic deficits and evidence of past events of neurologic symptoms (e.g., in the patient history). The neurologic symptoms themselves are notoriously variable and can come in virtually any form. Typical symptoms include paresthesia, weakness, ataxia, dysarthria, sensory deficits, and impaired or double vision.…
Imaging

Multiple Sclerosis

Preliminary Diagnosis: Multiple Sclerosis I. What imaging technique is first-line for this diagnosis? Contrasted MR of the brain per demyelinating protocol Contrasted MR of the cervical spine may additionally be performed to search for any cervical spine demyelinating plaques. II. Describe the advantages and disadvantages of this technique for diagnosis of multiple sclerosis. Advantages Highly…
News, Stat Consult

Stat Consult: Multiple Sclerosis

This review provides a concise overview of the types, pathogenesis, diagnostic criteria, differential diagnosis, and treatment of multiple sclerosis.
Web Exclusives

FDA approves Tecfidera for MS

Dimethyl fumarate is the third oral medication available to treat multiple sclerosis.
Evidence-Based Medicine

Dalfampridine approved for multiple sclerosis

Level 3: Lacking direct evidence Dalfampridine (Ampyra) extended release tablets, previously called Fampridine-SR, have been approved by the FDA to improve walking in patients with multiple sclerosis. In two clinical trials with 507 patients, the drug was associated with consistent improvement in walking speed on a 25-foot walk when compared with placebo (NNT 4). However,…
Next post in Evidence-Based Medicine